The Middle EAST Listeria Monocytogenes Infection Treatment Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.30 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by increasing awareness of Listeria infections, advancements in treatment methodologies, and a rising prevalence of foodborne illnesses. The region has witnessed a surge in...